SG Americas Securities, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$502
+0.8%
42,944
+43.1%
0.01%0.0%
Q1 2023$498
+67.1%
30,014
+87.4%
0.01%
+50.0%
Q4 2022$298
-99.9%
16,012
-34.9%
0.00%0.0%
Q3 2022$316,000
-50.2%
24,604
-72.8%
0.00%
-42.9%
Q2 2022$634,000
-25.2%
90,456
-11.5%
0.01%
+16.7%
Q1 2022$848,000
-40.7%
102,235
-51.6%
0.01%
-25.0%
Q4 2021$1,431,000
+199.4%
211,442
+134.2%
0.01%
+300.0%
Q3 2021$478,000
+1305.9%
90,273
+784.8%
0.00%
Q4 2020$34,000
-89.7%
10,203
-90.8%
0.00%
-100.0%
Q3 2020$330,000
+323.1%
111,142
+451.6%
0.00%
+100.0%
Q1 2020$78,000
-48.3%
20,148
-49.9%
0.00%0.0%
Q4 2019$151,000
+287.2%
40,236
+219.9%
0.00%
Q2 2018$39,000
-7.1%
12,576
-27.7%
0.00%
Q1 2018$42,000
-70.8%
17,385
-69.5%
0.00%
-100.0%
Q3 2017$144,000
+128.6%
57,050
+5.4%
0.00%
Q1 2016$63,000
-25.9%
54,123
+90.6%
0.00%
-100.0%
Q3 2015$85,00028,4000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders